Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 12:16PM ET
23.67
Dollar change
-0.02
Percentage change
-0.08
%
Index- P/E19.44 EPS (ttm)1.22 Insider Own0.07% Shs Outstand586.83M Perf Week-1.62%
Market Cap13.89B Forward P/E12.61 EPS next Y1.88 Insider Trans0.00% Shs Float586.39M Perf Month12.39%
Income714.56M PEG1.21 EPS next Q0.49 Inst Own5.70% Short Float0.15% Perf Quarter13.09%
Sales20.85B P/S0.67 EPS this Y5.12% Inst Trans1.74% Short Ratio3.16 Perf Half Y14.79%
Book/sh25.91 P/B0.91 EPS next Y27.91% ROA1.93% Short Interest0.85M Perf Year12.29%
Cash/sh2.61 P/C9.08 EPS next 5Y16.05% ROE4.76% 52W Range17.93 - 24.31 Perf YTD13.63%
Dividend Est.0.60 (2.55%) P/FCF8.18 EPS past 5Y-24.77% ROI2.76% 52W High-2.63% Beta0.92
Dividend TTM0.64 (2.72%) Quick Ratio1.02 Sales past 5Y1.53% Gross Margin25.13% 52W Low32.01% ATR (14)0.41
Dividend Ex-DateMay 17, 2024 Current Ratio1.37 EPS Y/Y TTM49.19% Oper. Margin8.49% RSI (14)64.77 Volatility1.08% 1.26%
Employees119845 Debt/Eq0.82 Sales Y/Y TTM0.42% Profit Margin3.43% Recom2.86 Target Price21.64
Option/ShortYes / Yes LT Debt/Eq0.70 EPS Q/Q154.99% Payout48.22% Rel Volume0.38 Prev Close23.69
Sales Surprise-2.42% EPS Surprise18.29% Sales Q/Q-2.62% EarningsNov 05 BMO Avg Volume269.73K Price23.67
SMA203.26% SMA5010.21% SMA20016.25% Trades Volume45,965 Change-0.08%
Date Action Analyst Rating Change Price Target Change
Dec-02-24Upgrade BofA Securities Underperform → Neutral
Nov-06-24Initiated Berenberg Buy $25.60
Jan-08-24Downgrade Morgan Stanley Equal-Weight → Underweight
Nov-24-23Upgrade HSBC Securities Reduce → Hold
Nov-17-23Upgrade Societe Generale Hold → Buy
Aug-14-23Downgrade UBS Buy → Neutral
Aug-01-23Resumed Citigroup Neutral
Jul-12-23Initiated Goldman Buy
Mar-07-23Initiated Bernstein Mkt Perform
Jan-03-23Downgrade Jefferies Buy → Underperform $14 → $11.70
Nov-19-24 09:00AM
Nov-06-24 06:33AM
Nov-05-24 10:19AM
07:00AM
02:05AM
11:04AM Loading…
Oct-21-24 11:04AM
Sep-10-24 07:51PM
Sep-04-24 08:00AM
Aug-07-24 08:57PM
Jul-30-24 02:43PM
07:00AM
Jul-08-24 07:59AM
Jun-19-24 09:40AM
Jun-12-24 08:00AM
Jun-11-24 02:23PM
11:02AM Loading…
Jun-07-24 11:02AM
May-30-24 07:07AM
May-23-24 12:33PM
May-21-24 10:00AM
May-16-24 09:55AM
08:50AM
May-08-24 11:23AM
May-07-24 01:53PM
01:01PM
07:00AM
01:36AM
Apr-10-24 09:36AM
Mar-25-24 11:10AM
10:59AM
10:46AM
08:00AM Loading…
Mar-22-24 08:00AM
Mar-19-24 08:00AM
Mar-15-24 10:14AM
Mar-11-24 09:42AM
Mar-06-24 05:02PM
Mar-05-24 03:34PM
10:10AM
10:09AM
Feb-21-24 09:36AM
02:49AM
Feb-20-24 01:10PM
07:30AM
01:44AM
Feb-17-24 03:19AM
Feb-08-24 08:54AM
Feb-05-24 08:57AM
Jan-08-24 08:16AM
Dec-06-23 09:52AM
Nov-30-23 07:00AM
Nov-27-23 08:13PM
Nov-23-23 06:47AM
Nov-22-23 08:28AM
Nov-21-23 04:07PM
Nov-10-23 08:52AM
Nov-08-23 04:00AM
Nov-03-23 09:34AM
08:54AM
Nov-02-23 01:34PM
12:36PM
02:38AM
Nov-01-23 06:15PM
05:33PM
07:46AM
Oct-31-23 07:12PM
09:28AM
08:00AM
Oct-30-23 12:36AM
Oct-26-23 09:58AM
Oct-24-23 02:18AM
01:22AM
Oct-23-23 05:59PM
10:15AM
09:15AM
Oct-20-23 09:40AM
Oct-18-23 08:00AM
Oct-16-23 07:17AM
Oct-12-23 12:55PM
12:18PM
11:53AM
Oct-11-23 01:56PM
12:18PM
12:06PM
11:52AM
11:39AM
11:25AM
10:33AM
08:00AM
06:02AM
Oct-04-23 08:29PM
Sep-15-23 08:20AM
Sep-06-23 10:28AM
Aug-24-23 08:43AM
Aug-23-23 09:01AM
Aug-09-23 09:00AM
Aug-03-23 10:55AM
Aug-02-23 05:56PM
09:45AM
05:03AM
Aug-01-23 09:02AM
Jul-14-23 02:32PM
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.